Abbott LaboratoriesABT
NYSE•Healthcare•Medical Devices
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $45.13B, growing 6.6% year-over-year. TTM net income stood at $6.28B (53.5% contraction). Quarterly EBITDA was $1.77B and operating income was $1.34B. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze ABT growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters